“o. itemList. length” “this. config. text. ariaShown”
“This. config. text. ariaFermé”
Following Russia’s claim of the world’s first coronavirus vaccine, about one hundred million doses are now sold to India.
To a rate that sets Moscow’s speed to accelerate its plans to distribute the questionable vaccine, dubbed Sputnik V, abroad, it accepted the dosages for Indian pharmaceutical company Dr. Reddy’s Laboratories.
The deal comes after the Russian Direct Investment Fund (RDIF) struck deals with Indian brands to produce three hundred million doses of the vaccine in India, which is a major customer for Russian oil and weapons.
Dr. Reddy’s, one of India’s leading pharmaceutical companies, will conduct III clinical trials of the vaccine in the country pending regulatory approval, RDIF said in a statement.
However, shipments to India, where coronavirus instances exceeded five million, can begin before the end of this year.
The Sputnik V vaccine has been the subject of controversy since Russian President Vladimir Putin said she registered for use in August and that one of her daughters had already been vaccinated.
German Health Minister Jens Spahn said he was skeptical of the claims and warned that, in the end, they may “end the acceptance” of vaccination as a weapon opposed to the pandemic.
And last week, scientists around the world signed an open letter expressing their fear that the effects of studies suggesting that the vaccine was “highly unlikely. “
In the letter, directed by Dr. Enrico Bucci of Temple University in Philadelphia, scientists wrote that “the public’s interest and excessive expectations for an effective vaccine” “motivate the clinical network to pay even more attention to the evidence. “
However, a team of Russian scientists concluded that there were no serious protective problems among the 36 volunteers who participated in the trials up to 42 days after administration of the vaccine.
Writing in the medical journal The Lancet, they added that the immune reaction had been in 40 volunteers in 21 days.
In response, medical experts from universities around the world published an open letter about the Italian Cattivi Scienziati, accusing Russian scientists of not providing “digital knowledge for all experiments. “
They added that the Lancet article highlights “several other issues of concern. “
Russia has ignored fear over its claims about the vaccine, calling the complaint “absolutely unfounded. “
His fitness minister, Mikhail Murashko, told the Interfax news agency: “It turns out that our foreign colleagues are feeling the explicit competitive benefits of Russian drugs and are seeking explicit criticism that Array . . . are surely unfounded. “
A possible vaccine developed in the UK may be in a position as soon as this year, after promising effects have been shown in the initial trials.
The UK government has signed an agreement with pharmaceutical giants GlaxoSmithKline (GSK) and Sanofi Pasteur to protect 60 million doses of a possible coronavirus vaccine.
Another agreement has been signed with AstraZeneca and oxford University for their jab, which can produce only one hundred million doses for the UK.
However, a recent survey found that some of the British would get a vaccine opposed to coronavirus if it developed.
Ipsos Mori’s survey of 2,237 adults found that 53% would be safe or most likely vaccinated, while one in six said they would not be vaccinated or would be highly unlikely.
Meanwhile, China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines, despite expert considerations for protecting drugs that have not completed popular testing.
China’s technique goes against that of many Western countries, where experts have warned that they oppose allowing vaccines that have completed testing as an emergency, due to possible side effects.
Click here to receive the latest news and data with our update newsletter